Exercise Training for Rectal Cancer Patients
NCT02538913 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2020-11-17
Summary
Cancer treatments often cause acute toxicity during treatment, and late toxicity after treatments have ended. Bowel dysfunctions, incontinence (anal and urinary) and dysfunction are late side effects associated with cancer treatment in general, and patients treated for pelvic malignancies are at a higher risk. In Norway, the incidence of rectal cancer was 1329 in 2010. Advances in the treatment during the past few decades have led to fewer local recurrences and increased long-term survival, and today the relative survival is 66% for women and 64% for men. More patients are having sphincter-preserving surgery with low colorectal or ultralow coloanal anastomoses, and low anterior resection (LAR) is done in 70% of the patients with curative surgery. Unfortunately, many patients experience altered bowel function after LAR. Frequent bowel movements, urgency, evacuatory difficulties and fecal incontinence are common and distressing complications. These functional disturbances are seen in up to 50-60% of the patients, and most frequent when surgery is combined with neoadjuvant therapy. Urinary incontinence and decreased sexual function is also common in both men and women following rectal cancer treatment.
In many surgical settings, patients with higher preoperative physical fitness rehabilitate more quickly and have fewer operative complications compared with patients who are less physically fit. Additionally, specific strength training of the pelvic floor muscles builds up muscle volume, elevates the location of the pelvic floor muscles and pelvic organs, and closes the levator hiatus thus providing improved structural support for the pelvic floor as well as more optimal automatic function. The aim of the present trial is to investigate whether exercise training including pelvic floor muscle training during preoperative radiotherapy can reduce symptoms of bowel, urinary and sexual dysfunction and affect the physiology of the anal sphincter muscle after LAR. In addition quality of life, cardiopulmonary parameters and postoperative complications will be studied.
Conditions
- Rectal Neoplasms
Interventions
- BEHAVIORAL
-
Exercise training
Daily pelvic floor muscle training and individualized regular exercise training (aerobic and strength exercise) three days per week.
- PROCEDURE
-
Usual care
Patients randomized to the control group will receive standard care which does not include any pelvic floor muscle training or individualized exercise training
Sponsors & Collaborators
-
St. Olavs Hospital
collaborator OTHER -
Norwegian University of Science and Technology
lead OTHER
Principal Investigators
-
Siri Forsmo, PhD, MD · Norwegian University of Science and Technology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2020-01-31
- Completion
- 2020-01-31
Countries
- Norway
Study Locations
More Related Trials
-
The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness
NCT01859442 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer
NCT05883800 ·Status: RECRUITING ·Phase: NA
-
Anal Cancer Radiotherapy Study
NCT01937780 ·Status: ACTIVE_NOT_RECRUITING
-
Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer
NCT06276686 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Curative Chemoradiation of Low Rectal Cancer
NCT02438839 ·Status: ACTIVE_NOT_RECRUITING
-
Ploidy and Stroma in Early Rectal Cancer
NCT03039595 ·Status: COMPLETED
-
Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology
NCT05664178 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
NCT05914766 ·Status: RECRUITING ·Phase: NA
-
Study of Short Course Radiation Therapy for Elderly Patients With Rectal Cancer
NCT04139967 ·Status: TERMINATED ·Phase: NA
-
Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum
NCT02641691 ·Status: COMPLETED ·Phase: PHASE2
-
"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.
NCT03402477 ·Status: TERMINATED
-
Individual Follow-up After Rectal Cancer - Focus on the Needs of the Patient
NCT03622437 ·Status: COMPLETED ·Phase: NA
-
Quality of Life in Patients With Rectal Cancer Receiving Total Mesorectal Excision With or Without Stoma
NCT03487484 ·Status: TERMINATED
-
Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients
NCT05816980 ·Status: COMPLETED ·Phase: PHASE2
-
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
NCT05274945 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Outcomes Following Anal Cancer Treatment
NCT01853059 ·Status: UNKNOWN
-
Nurse-or Surgeon-led Follow-up After Rectal Cancer
NCT01045200 ·Status: COMPLETED
-
Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT06542354 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer
NCT05622357 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer
NCT01613469 ·Status: TERMINATED ·Phase: PHASE2
-
Rectal Cancer CTC Trial
NCT07194616 ·Status: RECRUITING ·Phase: NA
-
Sexual Function and Wellbeing in Males With Rectal Cancer
NCT01216202 ·Status: COMPLETED
-
Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy
NCT02490709 ·Status: UNKNOWN ·Phase: PHASE2
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING